Articles
Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer’s disease associated with obesity, metabolic syndrome, and type 2 diabetes
No hay comentarios:
Publicar un comentario